Name: Relias Media
Price range: $

COX-2 Inhibitor Controversy

Current rofecoxib use was associated with a higher risk of acute myocardial infarction or admission for heart failure compared to celecoxib.

Cardiac-Resynchronization Therapy in Advanced Chronic Heart Failure

In selected patients, cardiac resynchronization therapy with a pacemaker or pacemaker-defibrillator improves their clinical course and the addition of a defibrillator with cardiac resynchronization therapy alone further reduces mortality.

Full June 28, 2004, Issue in PDF

Full May 31, 2004, Issue in PDF

Pulmonary Embolism: Recent Advances in Diagnosis and Treatment Modalities, Part II

This second and final part of a series covers the topics of differential diagnosis that must be considered when a patient presents with symptoms consistent with PE, treatment, and considerations for prevention of this disease state.